OncoSec Medical Incorporated

符号: ONCS

NASDAQ

0.2772

USD

今天的市场价格

-0.0457
市盈率
-0.0010
PEG比率
1.65M
MRK市值
0.00%
DIV收益率

OncoSec Medical Incorporated (ONCS) 财务报表

Q: 什么是 OncoSec Medical Incorporated (ONCS) 总资产是多少？

OncoSec Medical Incorporated (ONCS) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 OncoSec Medical Incorporated (ONCS). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 OncoSec Medical Incorporated 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009
balance-sheet.row.cash-and-short-term-investments	41.19	12.3	46	20.4	25.1	27	11.4	28.7	32	37.9	5	5.1	2.5	0	0	0
balance-sheet.row.short-term-investments	0	0	0	0	0	23.2	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	10.25	2.9	3.2	2.5	3.4	1.6	1.1	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-current-assets	51.44	15.2	49.2	22.8	28.5	28.6	12.5	29.4	33.6	38.3	5.2	5.5	2.9	0	0	0
balance-sheet.row.property-plant-equipment-net	17.97	5.6	6.4	6.8	1	1.3	2.4	2.8	1.8	0.6	0.2	0.1	0.1	0	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1.48	0.4	0.4	0	0	0	0	0	0	0.5	1.2	1.9	2.7	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	1.48	0.4	0.4	0	0	0	0	0	0	0.5	1.2	1.9	2.7	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	2.29	0.6	0.3	0.3	0.4	0.4	0.3	0.2	0.2	0	0	0	0	0	0	0
balance-sheet.row.total-non-current-assets	21.74	6.6	7.1	7.1	1.4	1.6	2.7	3	2	1.1	1.3	1.9	2.8	0	0	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	73.18	21.9	56.3	29.9	29.9	30.2	15.2	32.4	35.6	39.4	6.5	7.4	5.7	0	0	0
balance-sheet.row.account-payables	0	0	0	0	0	0	3.3	0	0	1.2	0.7	0.4	0.4	0	0	0
balance-sheet.row.short-term-debt	6.22	2	2.1	1.5	0.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	14.19	4.1	5.2	6.4	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	19.24	4.6	5.9	8.2	4.9	5.8	0.1	3.5	2.9	0.1	1	1.6	6.2	0	0	0
balance-sheet.row.total-non-current-liabilities	34.19	9.1	10.2	6.4	0.6	1.5	1.1	0.9	0	1.2	0.7	1	1.5	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	-1.2	-0.7	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	16.39	5.2	6.1	6.4	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	59.65	15.8	18.2	16	5.6	7.3	4.5	4.4	2.9	1.3	1.8	3	8	0	0	0
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-1158.6	-286	-251.8	-206.6	-164.4	-134.1	-94.9	-73.5	-46.6	-25.4	-13.4	-6.2	-3.8	-0.1	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	1.48	0.2	-0.1	0	0.2	0	0	-0.4	-0.3	-0.1	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1170.65	291.8	289.9	220.5	188.5	157	105.6	101522492	79276.8	63406.6	18.1	10.6	1.5	0	0	0
balance-sheet.row.total-stockholders-equity	13.54	6.1	38.1	13.9	24.3	22.9	10.7	28.1	32.7	38.1	4.7	4.4	-2.4	0	0	0
balance-sheet.row.total-liabilities-and-stockholders-equity	73.18	21.9	56.3	29.9	29.9	30.2	15.2	32.4	35.6	39.4	6.5	7.4	5.7	0	0	0
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	13.54	6.1	38.1	13.9	24.3	22.9	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	73.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0	23.2	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	20.41	6.2	7.3	7.8	0.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-debt	-20.78	-6.1	-38.6	-12.5	-25.1	-3.8	-11.4	-28.7	-32	-37.9	-5	-5.1	-2.5	0	0	0

现金流量表

在 OncoSec Medical Incorporated 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009
cash-flows.row.net-income	-29.39	-34.2	-45.2	-42.3	-30.3	-39.1	-21.4	-26.9	-21.2	-12	-7.2	-2.4	-3.8
cash-flows.row.depreciation-and-amortization	0.94	1.1	1.1	1	0.2	0.3	0.4	0.4	0.7	0.8	0.7	0.7	0.3
cash-flows.row.deferred-income-tax	0	0	-0.8	-0.1	0.2	0	0	0	0	0	0	0	-67.8
cash-flows.row.stock-based-compensation	1.28	1.6	5.1	3.5	3.5	8.3	4	6.1	2.6	1.8	0.5	0.3	67.8
cash-flows.row.change-in-working-capital	2.05	-1.2	-2.5	3.8	-3.5	2.2	-0.3	2.3	0.3	0.3	0.3	0	0.2
cash-flows.row.account-receivables	0	0	0	0	0	0	0	0	0	0	0	0	-391.2
cash-flows.row.inventory	0	0	0	0	0	0	0	0	0	0	0	0	38
cash-flows.row.account-payables	-1.38	-1.4	-2.6	3.6	-0.7	0	-0.2	0.9	1.1	0.7	0.3	0	353.2
cash-flows.row.other-working-capital	3.43	0.2	0.1	0.2	-2.8	2.2	-0.1	1.5	-0.8	-0.4	0	0	0.2
cash-flows.row.other-non-cash-items	0.12	0.6	0.5	0.9	0.8	5.2	0	0.3	0.1	0.2	0.1	-2.9	2
cash-flows.row.net-cash-provided-by-operating-activities	-24.99	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.24	-0.2	-0.8	0	0	-0.1	0	-1.6	-1.4	-0.5	-0.1	-0.1	-0.3
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	-25.5	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	23.2	2.3	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-0.26	-0.2	-0.8	0	23.2	-23.3	0	-1.6	-1.4	-0.5	-0.1	-0.1	-0.3
cash-flows.row.debt-repayment	-1.15	-1.3	-0.6	-0.1	-0.1	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	0.04	0	62.8	30	27.9	32.3	0	17.5	13.6	27.9	7.2	7.8	4.1
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	4.65	0.1	6	-1.5	-0.6	6.6	0.1	-1.4	-0.3	14.4	-1.7	-0.8	0
cash-flows.row.net-cash-used-provided-by-financing-activities	3.54	-1.2	68.2	28.4	27.2	38.9	0.1	16.1	13.3	42.4	5.5	7	4.1
cash-flows.row.effect-of-forex-changes-on-cash	-0.08	-0.1	0	0	-0.1	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-21.55	-33.7	25.6	-4.8	21.3	-7.6	-17.3	-3.3	-5.8	32.9	-0.2	2.7	2.5
cash-flows.row.cash-at-end-of-period	41.19	12.3	46	20.4	25.1	3.8	11.4	28.7	32	37.9	5	5.1	2.5
cash-flows.row.cash-at-beginning-of-period	62.74	46	20.4	25.1	3.8	11.4	28.7	32	37.9	5	5.1	2.5	0
cash-flows.row.operating-cash-flow	-24.99	-32.1	-41.8	-33.1	-29	-23.2	-17.3	-17.8	-17.7	-9	-5.5	-4.2	-1.3
cash-flows.row.capital-expenditure	-0.24	-0.2	-0.8	0	0	-0.1	0	-1.6	-1.4	-0.5	-0.1	-0.1	-0.3
cash-flows.row.free-cash-flow	-25.24	-32.4	-42.6	-33.1	-29	-23.3	-17.4	-19.4	-19.1	-9.5	-5.6	-4.3	-1.6

利润表行

OncoSec Medical Incorporated 的收入与上期相比变化了 NaN%。据报告, ONCS 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009
income-statement-row.row.total-revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.cost-of-revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	21.77	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	10.88	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.06	0	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.operating-expenses	32.65	37	48.4	43.4	30.4	36.1	21.4	26.9	21.2	11.9	7.1	5.5	1.7	0	0	0
income-statement-row.row.cost-and-expenses	32.65	37	48.4	43.4	30.4	36.1	21.4	26.9	21.2	11.9	7.1	5.5	1.7	0	0	0
income-statement-row.row.interest-income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.05	0	0	0	0	6.4	0	0	0	0	0.1	-3.2	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-0.07	-0.5	0.8	0.3	0.1	-3	0	0	0	0	-0.1	3.2	-2.1	0	0	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.06	0	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.total-operating-expenses	-0.07	-0.5	0.8	0.3	0.1	-3	0	0	0	0	-0.1	3.2	-2.1	0	0	0
income-statement-row.row.interest-expense	0.05	0	0	0	0	6.4	0	0	0	0	0.1	-3.2	0	0	0	0
income-statement-row.row.depreciation-and-amortization	0.99	1.1	1.1	1.2	0.7	3.7	0.4	0.4	0.7	0.8	0.7	0.7	0.3	0	0	0
income-statement-row.row.ebitda-caps	-31.66	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-32.65	-37	-48.4	-43.4	-30.4	-36.1	-21.4	-26.9	-21.2	-11.9	-7.1	-5.5	-1.7	0	0	0
income-statement-row.row.income-before-tax	-32.72	-37.5	-47.6	-43.1	-30.3	-39.1	-21.4	-26.9	-21.2	-12	-7.1	-2.4	-3.8	0	0	0
income-statement-row.row.income-tax-expense	-2.58	-3.3	-2.4	-0.9	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.net-income	-30.14	-34.2	-45.2	-42.3	-30.3	-39.1	-21.4	-26.9	-21.2	-12	-7.2	-2.4	-3.8	0	0	0